Bliss GVS Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	351.42	237.94	231.4	249.55	219.15
Short-Term Investments	-	1,520	1,176	1,167	384.44	1,130
Trading Asset Securities	-	14.46	-	5.57	49.6	-
Cash & Short-Term Investments	1,886	1,886	1,413	1,404	683.59	1,349
Cash Growth	33.46%	33.46%	0.70%	105.34%	-49.34%	118.83%
Accounts Receivable	-	5,172	4,388	4,043	3,852	3,928
Other Receivables	-	90.54	88.82	134.02	57.8	119.38
Receivables	-	5,263	4,477	4,178	3,910	4,048
Inventory	-	1,507	1,257	1,184	1,031	1,239
Prepaid Expenses	-	41.7	24.7	27.76	24.21	31.9
Other Current Assets	-	765.17	1,066	1,315	1,325	1,100
Total Current Assets	-	9,463	8,238	8,109	6,974	7,769
Property, Plant & Equipment	-	4,567	4,177	3,694	3,729	2,948
Long-Term Investments	-	339.37	310.67	80.2	568.59	36.75
Goodwill	-	77.11	77.11	77.11	77.11	77.11
Other Intangible Assets	-	2.14	2.3	1.07	2.29	3.83
Long-Term Deferred Tax Assets	-	163.01	-	-	33.33	-
Other Long-Term Assets	-	311.87	207.29	154.99	184.42	252.93
Total Assets	-	14,924	13,013	12,116	11,569	11,087

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Accounts Payable	-	1,042	714.18	609.65	863.9	926.06
Accrued Expenses	-	133.87	70.43	58.08	55.09	47.86
Short-Term Debt	-	27.53	228.92	324.17	460.14	607.03
Current Portion of Long-Term Debt	-	1.73	282.37	197.98	113.63	210.32
Current Portion of Leases	-	55.23	44.1	27.55	11.14	9.42
Current Income Taxes Payable	-	300.04	37.74	18.66	26.56	66.49
Current Unearned Revenue	-	61.78	45.7	69.24	34.7	90.08
Other Current Liabilities	-	733.16	298.21	268.73	367.44	373.6
Total Current Liabilities	-	2,355	1,722	1,574	1,933	2,331
Long-Term Debt	-	-	198.46	355.92	406.9	232.22
Long-Term Leases	-	133.01	127.19	92.79	27.17	34.92
Long-Term Unearned Revenue	-	0.2	0.47	0.61	0.74	0.87
Pension & Post-Retirement Benefits	-	20.66	33.63	26.74	26.89	10.74
Long-Term Deferred Tax Liabilities	-	-	3	35.93	-	13.23
Other Long-Term Liabilities	-	97.25	10.01	-	-	-
Total Liabilities	-	2,607	2,094	2,086	2,394	2,623

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Common Stock	-	105.79	105.37	104.69	104.15	103.68
Additional Paid-In Capital	-	447.88	404.24	331.64	269.94	212.77
Retained Earnings	-	11,312	10,120	9,324	8,603	7,941
Comprehensive Income & Other	-	63.79	-126.06	-88.46	-138.53	-70.73
Total Common Equity	11,929	11,929	10,504	9,672	8,839	8,187
Minority Interest	-	388.6	414.71	357.9	335.27	277.6
Shareholders' Equity	12,318	12,318	10,918	10,030	9,174	8,465
Total Liabilities & Equity	-	14,924	13,013	12,116	11,569	11,087

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Total Debt	217.5	217.5	881.04	998.4	1,019	1,094
Net Cash (Debt)	1,669	1,669	532.41	405.27	-335.39	255.5
Net Cash Growth	213.45%	213.45%	31.37%	-	-	-
Net Cash Per Share	15.47	15.51	5.02	3.82	-3.18	2.43
Filing Date Shares Outstanding	105.91	105.79	105.37	104.69	104.15	103.68
Total Common Shares Outstanding	105.91	105.79	105.37	104.69	104.15	103.68
Working Capital	-	7,108	6,517	6,535	5,041	5,438
Book Value Per Share	112.76	112.76	99.68	92.39	84.87	78.97
Tangible Book Value	11,850	11,850	10,424	9,594	8,760	8,106
Tangible Book Value Per Share	112.01	112.01	98.93	91.64	84.10	78.19
Land	-	434.67	422.36	409.88	419.83	420.09
Buildings	-	1,465	1,360	1,369	1,437	1,059
Machinery	-	3,740	3,152	2,616	2,580	1,809
Construction In Progress	-	60.46	207.11	78.27	28.01	221.55